1. Home
  2. ASTH vs AMPH Comparison

ASTH vs AMPH Comparison

Compare ASTH & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTH
  • AMPH
  • Stock Information
  • Founded
  • ASTH 1994
  • AMPH 1996
  • Country
  • ASTH United States
  • AMPH United States
  • Employees
  • ASTH N/A
  • AMPH N/A
  • Industry
  • ASTH Professional Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASTH Consumer Discretionary
  • AMPH Health Care
  • Exchange
  • ASTH Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • ASTH 1.3B
  • AMPH 1.2B
  • IPO Year
  • ASTH N/A
  • AMPH 2014
  • Fundamental
  • Price
  • ASTH $32.02
  • AMPH $23.84
  • Analyst Decision
  • ASTH Strong Buy
  • AMPH Buy
  • Analyst Count
  • ASTH 5
  • AMPH 6
  • Target Price
  • ASTH $47.40
  • AMPH $35.50
  • AVG Volume (30 Days)
  • ASTH 325.5K
  • AMPH 432.8K
  • Earning Date
  • ASTH 11-06-2025
  • AMPH 11-05-2025
  • Dividend Yield
  • ASTH N/A
  • AMPH N/A
  • EPS Growth
  • ASTH N/A
  • AMPH N/A
  • EPS
  • ASTH 0.52
  • AMPH 2.68
  • Revenue
  • ASTH $2,419,115,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • ASTH $60.87
  • AMPH $1.37
  • Revenue Next Year
  • ASTH $27.04
  • AMPH $6.93
  • P/E Ratio
  • ASTH $60.65
  • AMPH $8.67
  • Revenue Growth
  • ASTH 51.97
  • AMPH 1.37
  • 52 Week Low
  • ASTH $21.20
  • AMPH $20.39
  • 52 Week High
  • ASTH $63.20
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • ASTH 64.08
  • AMPH 34.25
  • Support Level
  • ASTH $28.81
  • AMPH $22.94
  • Resistance Level
  • ASTH $31.18
  • AMPH $24.20
  • Average True Range (ATR)
  • ASTH 1.20
  • AMPH 0.87
  • MACD
  • ASTH 0.30
  • AMPH -0.26
  • Stochastic Oscillator
  • ASTH 100.00
  • AMPH 20.67

About ASTH Astrana Health Inc. Common Stock

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: